Vanguard Personalized Indexing Management, LLC Viking Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $8.6 Billion
- Q2 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 14,607 shares of VKTX stock, worth $350,568. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,607
Previous 10,828
34.9%
Holding current value
$350,568
Previous $261,000
48.28%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VKTX
# of Institutions
454Shares Held
68.3MCall Options Held
7.72MPut Options Held
3.31M-
Vanguard Group Inc Valley Forge, PA10.2MShares$244 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$145 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$90.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.25MShares$77.9 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY3.13MShares$75 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $1.84B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...